| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $1.6B | $0.9B | $0.8B | $0.8B | $0.7B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B |
| SG&A Expense | $0.2B | $0.3B | $0.1B | $0.1B | $0.1B |
| Operating Income | $0.1B | $-0.1B | $0.1B | $0.1B | $0.1B |
| Net Income | $-0.0B | $-0.1B | $0.0B | $0.1B | $0.0B |
| EPS (Basic) | $-0.20 | $-0.74 | $0.26 | $0.43 | $0.11 |
| EPS (Diluted) | $-0.20 | $-0.74 | $0.26 | $0.43 | $0.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $3.8B | $3.9B | $1.6B | $1.9B | $1.9B |
| Current Assets | $0.6B | $0.5B | $0.4B | $0.6B | $0.5B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.4B | $0.3B |
| Total Liabilities | $2.5B | $2.6B | $0.7B | $0.8B | $0.8B |
| Current Liabilities | $0.2B | $0.3B | $0.1B | $0.1B | $0.1B |
| Stockholders' Equity | $1.3B | $1.3B | $0.9B | $1.1B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.0B | $0.2B | $0.2B | $0.1B |
| Investing Cash Flow | $-0.1B | $-1.7B | $-0.1B | $-0.0B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.1B | $1.6B | $-0.3B | $-0.1B | $0.1B |